KHRC Receives 'Clinical Trial Facility of the Year' Award at the Maiden Ghana Pharma Excellence Awards

April 12, 2025 | News Feed | Reading time: 3 min

The Kintampo Health Research Centre (KHRC) has been honoured with the “Excellence in Pharma Research: Clinical Trial Facility of the Year” award at the maiden edition of the Ghana Pharma Excellence Awards, held in Accra on Friday, April 11, 2025.

This distinguished award recognizes KHRC’s exceptional dedication, innovation, and impact in the field of clinical trial research. As a Centre of excellence under the Ghana Health Service, KHRC has made significant contributions to advancing global health through rigorous, high-quality research that supports the development of new treatments and improves patient care.

The maiden edition of the Ghana Pharma Excellence Awards was organized by the Pharmaceutical Society of Ghana (PSGH) to celebrate outstanding achievements within the pharmaceutical industry and healthcare sector. The event brought together industry leaders, professionals, and stakeholders to honour excellence in diverse categories such as professional practice, manufacturing, research and development, regulatory compliance, pharmaceutical care, entrepreneurship, and corporate social responsibility.

Over the past three decades, KHRC has successfully conducted Phase I to Phase IV clinical trials for various vaccines and drugs, including the RTS,S malaria vaccine, COVID-19 vaccine candidates, treatments for sickle cell disease and malaria, RSV and Lassa fever vaccines, among others. Many of these interventions have since been approved for global use and are contributing to the treatment and prevention of major diseases. KHRC’s recognition as Clinical Trial Facility of the Year therefore underscores its important role in advancing ethical and impactful research that strengthens healthcare delivery and improves access to quality medical care.

The award was received on behalf of KHRC by Pharm. Elvis Ato Wilson, Senior Pharmacist in the Clinical Trials Department. KHRC expresses its sincere gratitude for this recognition and reaffirms its commitment to ethical, high-quality research that contributes to both national and global public health goals.

Learn more about KHRC’s clinical trials research: https://www.kintampo-

Clinical Trials